The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system
Abstract
Myelin oligodendrocyte glycoprotein (MOG)‐specific T cells mediate an autoimmune inflammatory response in the central nervous system (CNS) that differs radically from conventional models of T cell‐mediated experimental allergic encephalomyelitis (EAE). Using synthetic peptides an encephalitogenic T cell epitope of MOG for the Lewis rat was identified within the extracellular IgG V‐like domain of the protein, amino acids 44‐53 (FSRVVHLYRN).The adoptive transfer of CD4+ T cells specific for this epitope induce an intense, dose‐dependent inflammatory response in the CNS of naive syngeneic recipients. However, unlike the inflammatory response induced by myelin basic protein (MBP)‐specific T cell lines, inflammation mediated by the MOG peptide‐specific T cells failed to induce a gross neurological deficit. This unexpected observation was not due to a reduction in the overall inflammatory response in the CNS, but was specifically associated with a decrease in the extent of parenchymal (as opposed to perivascular) inflammation, a selective decrease in the number of ED1+ macrophages infiltrating the CNS, and a total lack of peripheral nerve inflammation. The decreased recruitment of macrophages into the CNS could not be ascribed to deficiences in the synthesis of interferon‐γ, tumor necrosis factor‐a, interleukin (IL)‐6 or IL‐2 by the T cell line. Moreover, this sub‐clinical inflammatory response induced severe blood‐brain barrier dysfunction as demonstrated by the induction of severe clinical disease following intravenous injection of a demyelinating MOG‐specific monoclonal antibody. The neurological deficit in EAE thus exhibits an unexpected dependence on the identity of the target autoantigen, which determines the extent and nature of the local inflammatory response and ultimately the extent of the neurological deficit.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961
Ben‐Nun, A., Wekerle, H., & Cohen, I. R. (1981) · European Journal of Immunology · doi:10.1002/eji.1830110307 · Cited by 916
Self-citationCellular immune reactivity within the CNS
Wekerle, H., Linington, C., Lassmann, H., & Meyermann, R. (1986) · Trends in Neurosciences · doi:10.1016/0166-2236(86)90077-9 · Cited by 768
Self-citationLinington, C., Bradl, M., Lassmann, H., Brunner, C., & Vass, K. (1988) · PubMed · Cited by 708
Self-citationMYELINATION IN RAT BRAIN: CHANGES IN MYELIN COMPOSITION DURING BRAIN MATURATION1
Norton, W. T., & Poduslo, S. E. (1973) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1973.tb07520.x · Cited by 668
Huitinga, I., van Rooijen, N., de Groot, C. J., Uitdehaag, B. M., & Dijkstra, C. D. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.4.1025 · Cited by 506
Remyelination in multiple sclerosis
Prineas, J. W., & Connell, F. (1979) · Annals of Neurology · doi:10.1002/ana.410050105 · Cited by 454
Remyelination in multiple sclerosis
Piaton, G., Williams, A., Seilhean, D., & Lubetzki, C. (2009) · Progress in Brain Research · doi:10.1016/s0079-6123(09)17530-1 · Cited by 441
Brunner, C., Lassmann, H., Waehneldt, T. V., Matthieu, J., & Linington, C. (1989) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1989.tb10930.x · Cited by 409
Self-citationSchluesener, H. J., Sobel, R. A., Linington, C., & Weiner, H. L. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.139.12.4016 · Cited by 371
Self-citationA novel myelin-associated glycoprotein defined by a mouse monoclonal antibody
Linnington, C., Webb, M., & Woodhams, P. L. (1984) · Journal of Neuroimmunology · doi:10.1016/0165-5728(84)90064-x · Cited by 321
T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis
Sun, J., Link, H., Olsson, T., Xiao, B. G., Andersson, G., Ekre, H. P., Linington, C., & Diener, P. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.146.5.1490 · Cited by 315
Self-citationComparative Neuropathology of Chronic Experimental Allergic Encephalomyelitis and Multiple Sclerosis
Lassmann, H. (1983) · Schriftenreihe Neurologie / Neurology Series · doi:10.1007/978-3-642-45558-2 · Cited by 296
Self-citationMultiple sclerosis: Capping of surface immunoglobulin G on macrophages engaged in myelin breakdown
Prineas, J. W., & Graham, J. S. (1981) · Annals of Neurology · doi:10.1002/ana.410100205 · Cited by 264
Myelin/oligodendrocyte glycoprotein is a unique member of the immunoglobulin superfamily
Gardinier, M. V., Amiguet, P., Linington, C., & Matthieu, J. ‐. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490330123 · Cited by 244
Self-citationVass, K., & Lassmann, H. (1990) · Europe PMC (PubMed Central) · Cited by 238
Self-citationLinington, C., & Lassmann, H. (1987) · Journal of Neuroimmunology · doi:10.1016/0165-5728(87)90031-2 · Cited by 221
Self-citationBrosnan, C. F., Bornstein, M. B., & Bloom, B. R. (1981) · The Journal of Immunology · doi:10.4049/jimmunol.126.2.614 · Cited by 219
Lassmann, H., Brunner, C., Bradl, M., & Linington, C. (1988) · Acta Neuropathologica · doi:10.1007/bf00686201 · Cited by 206
Self-citationXiao, B.-G., Linington, C., & Link, H. (1991) · Journal of Neuroimmunology · doi:10.1016/0165-5728(91)90014-x · Cited by 197
Self-citationIMMUNOCYTOCHEMICAL LOCALIZATION OF THE TERMINAL COMPLEMENT COMPLEX IN MULTIPLE SCLEROSIS
COMPSTON, D. A. S., MORGAN, B. P., CAMPBELL, A. K., WILKINS, P., COLE, G., THOMAS, N. D., & JASANI, B. (1989) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.1989.tb01231.x · Cited by 185
Induction of stress protein HSP70 in nerve cells after status epilepticus in the rat
Vass, K., Berger, M. L., Nowak, T. S., Welch, W. J., & Lassmann, H. (1989) · Neuroscience Letters · doi:10.1016/0304-3940(89)90695-2 · Cited by 178
Self-citationThe immunogenesis of the multiple sclerosis plaque
Lumsden, C. E. (1971) · Brain Research · doi:10.1016/0006-8993(71)90052-7 · Cited by 170
Electron microscopic studies on ordinary and hyperacute experimental allergic encephalomyelitis
Lampert, P. (1967) · Acta Neuropathologica · doi:10.1007/bf00691436 · Cited by 168
de Rosbo, N. K., Honegger, P., Lassmann, H., & Matthieu, J. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04173.x · Cited by 166
Self-citationTHE ROLE OF COMPLEMENT IN THE PATHOGENESIS OF EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS
Linington, C., Morgan, B. P., Scolding, N. J., Wilkins, P. R., Piddlesden, S. J., & Compston, D. A. S. (1989) · Brain · doi:10.1093/brain/112.4.895 · Cited by 156
Self-citationLinington, C., Engelhardt, B., Kapócs, G., & Lassman, H. (1992) · Journal of Neuroimmunology · doi:10.1016/0165-5728(92)90136-9 · Cited by 145
Self-citationEYLAR, E. H., Kniskern, P. J., & Jackson, J. J. (1974) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(74)32034-4 · Cited by 112
Augmentation of immune-mediated demyelination by lipid haptens.
Raine, C. S., Traugott, U., Farooq, M., Mb, B., & Wt, N. (1981) · PubMed · Cited by 106
Piddlesden, S. J., Lassmann, H., Laffafian, I., Morgan, B. P., & Linington, C. (1991) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.1991.tb05622.x · Cited by 85
Self-citationCloning and expression in Escherichia coli of the gene for rat tumor necrosis factor.
SHIRAI, T., Shimizu, N., Horiguchi, S., & Ito, H. (1989) · Agricultural and Biological Chemistry · doi:10.1271/bbb1961.53.1733 · Cited by 60
Linington, C., Lassmann, H., Morgan, B. P., & Compston, D. A. S. (1989) · Acta Neuropathologica · doi:10.1007/bf00308961 · Cited by 58
Self-citationRaine, C. S., Traugott, U., Rb, N., & Sh, S. (1980) · PubMed · Cited by 29
Passive transfer of experimental allergic encephalomyelitis induced by proteolipid apoprotein
Yamamura, T., Namikawa, T., Endoh, M., Kunishita, T., & Tabira, T. (1986) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(86)90174-7 · Cited by 16
Vandenbark, A. A., Nilaver, G., Konat, G. W., Teal, P., & Offner, H. (1986) · Journal of Neuroscience Research · doi:10.1002/jnr.490160406 · Cited by 14
Cited by
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Gold, R. (2006) · Brain · doi:10.1093/brain/awl075 · Cited by 1,017
“Immunopathological studies revealed that this dichotomy between the lesion density and the intensity of the clinical deficit was due to the failure of MOG-specific T cells to recruit macrophages into the CNS (Linington et al., 1993).”
BackgroundBettelli, E., Pagany, M., Weiner, H. L., Linington, C., Sobel, R. A., & Kuchroo, V. K. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20021603 · Cited by 825
Self-citationMendel, I., de Rosbo, N. K., & Ben‐Nun, A. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250723 · Cited by 601
TNF is a potent anti-inflammatory cytokine in autoimmune-mediated demyelination
Liu, J., Marino, M. W., Wong, G., Grail, D., Dunn, A., Bettadapura, J., Slavin, A. J., Old, L., & Bernard, C. C. A. (1998) · Nature Medicine · doi:10.1038/nm0198-078 · Cited by 550
Metadata
- Authors
- Linington, C., Berger, T., Perry, L., Weerth, S., Hinze‐Selch, D., Zhang, Y., Lu, H., Lassmann, H., & Wekerle, H.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1993-06
- Volume
- 23
- Issue
- 6
- Pages
- 1364-1372
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W2031355573
- Cited by
- 267
- References
- 35
- FWCI
- 13.21
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.